Claritin-D 24 Hour

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instance_of gptkb:fragrance
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:Claritin
gptkbp:age 12 years and older
gptkbp:approves gptkb:2000
gptkbp:body_style oval
gptkbp:class gptkb:drug
decongestant
gptkbp:clinical_trial gptkb:battle
gptkbp:color gptkb:blue
gptkbp:contains gptkb:loratadine
gptkb:pseudoephedrine
gptkbp:contraindication MAO inhibitors
severe hypertension
gptkbp:countermeasures gptkb:battle
gptkbp:dosage_form extended-release tablet
1 tablet every 24 hours
gptkbp:formulation 24-hour extended release
gptkbp:healthcare gptkb:battle
https://www.w3.org/2000/01/rdf-schema#label Claritin-D 24 Hour
gptkbp:imprints CLARITIN-D 24 HR
gptkbp:indication perennial allergic rhinitis
seasonal allergic rhinitis
gptkbp:ingredients gptkb:loratadine
pseudoephedrine sulfate
gptkbp:interacts_with gptkb:beer
other antihistamines
certain antidepressants
gptkbp:is_available_in various strengths
gptkbp:is_available_on gptkb:tablet
gptkbp:is_used_for nasal congestion
relief of allergy symptoms
gptkbp:manufacturer gptkb:physicist
gptkbp:marketed_as gptkb:Claritin-D
gptkbp:packaging blister pack
gptkbp:previous_name gptkb:battle
gptkbp:related_to gptkb:Claritin
gptkb:pseudoephedrine
gptkbp:requires gptkb:battle
gptkbp:safety_features do not exceed recommended dose
may cause dizziness
consult a doctor if pregnant or breastfeeding
may cause increased heart rate
not for children under 12 without doctor advice
gptkbp:side_effect drowsiness
insomnia
dry mouth
nervousness
gptkbp:storage store at room temperature